Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,786 Cr
up ₹130 Cr vs Sep 2022
- Stocks held
- 29
- up 1 vs Sep 2022
- Top 10 weight
- 66.7%
- of the portfolio in its ten largest
- Cash & debt
- 2.1%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 12
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In October 2022 it disclosed 29 stocks worth ₹4,786 Cr, up ₹130 Cr from Sep 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.9%), Cipla Limited (9.0%), Dr. Reddy's Laboratories Limited (8.2%); the ten largest together made up 66.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 80.1% of its equity. Cash and debt stood at 2.1%. Compared with Sep 2022 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
31%
Holds more cash than 31% of peers
Holdings in October 2022
Download CSVEvery line the fund disclosed, with the change against Sep 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.88%
- Δ weight
- up <0.01 pts
- Value
- ₹712 Cr
- Δ value
- up ₹19.3 Cr
- Status
- Added
- Weight
- 9.03%
- Δ weight
- up 0.17 pts
- Value
- ₹432 Cr
- Δ value
- up ₹19.4 Cr
- Status
- Added
- Weight
- 8.20%
- Δ weight
- down 0.04 pts
- Value
- ₹392 Cr
- Δ value
- up ₹8.7 Cr
- Status
- Added
- Weight
- 6.57%
- Δ weight
- up <0.01 pts
- Value
- ₹315 Cr
- Δ value
- up ₹8.6 Cr
- Status
- Added
- Weight
- 5.20%
- Δ weight
- down 0.11 pts
- Value
- ₹249 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 5.05%
- Δ weight
- up 0.14 pts
- Value
- ₹242 Cr
- Δ value
- up ₹13.2 Cr
- Status
- Added
- Weight
- 4.96%
- Δ weight
- down 0.30 pts
- Value
- ₹238 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 4.90%
- Δ weight
- down 1.07 pts
- Value
- ₹235 Cr
- Δ value
- down ₹43.3 Cr
- Status
- Trimmed
- Weight
- 3.97%
- Δ weight
- up 0.34 pts
- Value
- ₹190 Cr
- Δ value
- up ₹21 Cr
- Status
- Added
- Weight
- 3.94%
- Δ weight
- up 0.10 pts
- Value
- ₹188 Cr
- Δ value
- up ₹9.6 Cr
- Status
- Added
- Weight
- 3.35%
- Δ weight
- down 0.27 pts
- Value
- ₹160 Cr
- Δ value
- down ₹8.3 Cr
- Status
- Trimmed
- Weight
- 3.25%
- Δ weight
- up 0.07 pts
- Value
- ₹155 Cr
- Δ value
- up ₹7.4 Cr
- Status
- Added
- Weight
- 3.13%
- Δ weight
- up 0.51 pts
- Value
- ₹150 Cr
- Δ value
- up ₹27.6 Cr
- Status
- Added
- Weight
- 2.68%
- Δ weight
- down <0.01 pts
- Value
- ₹128 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 2.61%
- Δ weight
- down 0.15 pts
- Value
- ₹125 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 2.42%
- Δ weight
- down 0.20 pts
- Value
- ₹116 Cr
- Δ value
- down ₹6.3 Cr
- Status
- Trimmed
- Weight
- 2.37%
- Δ weight
- down 0.29 pts
- Value
- ₹113 Cr
- Δ value
- down ₹10.4 Cr
- Status
- Trimmed
- Weight
- 2.24%
- Δ weight
- down 0.46 pts
- Value
- ₹107 Cr
- Δ value
- down ₹18.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 2.08%
- Δ weight
- up 1.73 pts
- Value
- ₹99.6 Cr
- Δ value
- up ₹83 Cr
- Status
- Added
- Weight
- 1.95%
- Δ weight
- down 0.02 pts
- Value
- ₹93.3 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 1.86%
- Δ weight
- down 0.13 pts
- Value
- ₹89.1 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 1.36%
- Δ weight
- up 0.07 pts
- Value
- ₹65 Cr
- Δ value
- up ₹4.8 Cr
- Status
- Added
- Weight
- 1.14%
- Δ weight
- down 0.04 pts
- Value
- ₹54.4 Cr
- Δ value
- down ₹59 L
- Status
- Trimmed
- Weight
- 0.81%
- Δ weight
- up 0.12 pts
- Value
- ₹38.8 Cr
- Δ value
- up ₹6.8 Cr
- Status
- Added
- Weight
- 0.52%
- Δ weight
- down 0.03 pts
- Value
- ₹24.8 Cr
- Δ value
- down ₹85 L
- Status
- Trimmed
- Weight
- 0.42%
- Δ weight
- up 0.03 pts
- Value
- ₹20.2 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 0.41%
- Δ weight
- down 0.20 pts
- Value
- ₹19.8 Cr
- Δ value
- down ₹8.7 Cr
- Status
- Trimmed
- Weight
- 0.36%
- Δ weight
- down 0.04 pts
- Value
- ₹17.3 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 0.24%
- Δ weight
- down <0.01 pts
- Value
- ₹11.5 Cr
- Δ value
- up ₹9 L
- Status
- Added
- Weight
- 0.11%
- Δ weight
- up 0.11 pts
- Value
- ₹5 Cr
- Δ value
- up ₹5 Cr
- Status
- New
What changed, Sep 2022 to Oct 2022
New New positions (1)
- Syngene International Limited0.1% · ₹5 Cr
Exited Exited (0)
None.
Added Biggest additions
- Zydus Lifesciences Limitedup ₹27.6 Cr (+0.51% pts)
- Apollo Hospitals Enterprise Limitedup ₹21 Cr (+0.34% pts)
- Cipla Limitedup ₹19.4 Cr (+0.17% pts)
- Sun Pharmaceutical Industries Limitedup ₹19.3 Cr (+<0.01% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2022, the weight rose most in Pharmaceuticals & Biotechnology (+0.1 pts), and fell most in Healthcare Services (−0.2 pts).
- Pharmaceuticals & Biotechnology80.0% → 80.1%+0.1 pts
- Healthcare Services18.3% → 18.1%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2019 | Oct 2021 | Apr 2022 | Jul 2022 | Sep 2022 | Oct 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.2% | 76.2% | 78.4% | 80.4% | 80.0% | 80.1% |
| Healthcare Services | 21.1% | 21.6% | 19.3% | 17.4% | 18.3% | 18.1% |
| Pharmaceuticals | 0.7% | 2.2% | 1.8% | 1.5% | 1.3% | 1.4% |
| Healthcare Equipment & Supplies | — | — | 0.6% | 0.6% | 0.4% | 0.4% |
Allocation in Oct 2022change vs Sep 2022
- Pharmaceuticals & Biotechnology (19)80.1%▲ 0.1 pts
- Healthcare Services (8)18.1%▼ 0.2 pts
- Pharmaceuticals (1)1.4%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2022
2.1%
▲ 1.7 pts vs Sep 2022
- Cash alone
- 2.1%
- cash and net receivables
- A year earlier
- 4.6%
- Oct 2021 · now ▼ 2.6 pts
- Last 12 months
- 0.3% – 4.1%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.